Furthermore, Valentino et al. found that, in breast and prostate cancers, p53-R175H and p53-R280K can induce PI3K/AKT signaling pathway and promote tumor growth by binding to tumor suppressor DAB2IP. Here, PIK3CG is linked to neoplasm.